Advertisement

Topics

Samsung Bioepis ventures into novel R&D with Takeda deal

07:12 EDT 22 Aug 2017 | PharmaTimes

Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.

Original Article: Samsung Bioepis ventures into novel R&D with Takeda deal

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis ventures into novel R&D with Takeda deal"

Advertisement
Quick Search
Advertisement
Advertisement